Heze Development Zone chuangli Chemical Co., Ltd.

Heze Development Zone chuangli Chemical Co., Ltd.

Current Location: HOME >> Product
Product Categories
Country: China
Tel: 0530-+86-530-529 6766,+86-15666160102
Mobile: 15666160102
E-mail:
QQ:
Skype: Chat Now!
Product Name MF CAS Details
GZD824 C29H27F3N6O 1257628-77-5 Details
PLX8394 C25H21F3N6O3S 1393466-87-9 Details
Selonsertib C24H24FN7O 1448428-04-3 Details
NLG919 C18H22N2O 1402836-58-1 Details
PTC-124 C15H9FN2O3 775304-57-9 Details
IDO-IN-1 C9H7BrFN5O2 914638-30-5 Details
PD98059 C16H13NO3 167869-21-8 Details
poziotinib C23H21Cl2FN4O3 1092364-38-9 Details
2-Pyridineacetic acid, 6-methyl- (9CI) C8H9NO2 92917-49-2 Details
1-(AMINOMETHYL)CYCLOPROPANECARBOXYLIC ACID C5H9NO2 139126-45-7 Details
4-Chlorothieno[3,2-d]pyrimidine C6H3ClN2S 16269-66-2 Details
2-Bromo-5-formyl-3-methylpyridine C7H6BrNO 885167-81-7 Details
4-amino-2-chloronicotinaldehyde C6H5ClN2O 338452-92-9 Details
(3-chloropyrazin-2-yl)methanamine hydrochloride C5H7Cl2N3 867165-53-5 Details
Capromorelin C28H35N5O4 193273-66-4 Details
2-AMino-3-forMyl-4-chloropyridine C6H5ClN2O 884004-48-2 Details
2-CHLORO-5-FORMYL-4-PICOLINE C7H6ClNO 884495-38-9 Details
4-BENZYLOXYBUTYRIC ACID C11H14O3 10385-30-5 Details
1-(4-BROMOPHENYL)PIPERAZINE C10H13BrN2 66698-28-0 Details
(5-chloropyridin-2-yl)MethanaMine dihydrochloride C6H8Cl2N2 1257535-54-8 Details
3-IODO-4-METHOXY-PYRIDIN-2-YLAMINE C6H7IN2O 956485-64-6 Details
DCC2701 (Altiratinib) C26H21F3N4O4 1345847-93-9 Details
6-BroMo-4-Methyl-pyridine-3-carbaldehyde C7H6BrNO 926294-07-7 Details
LDN-193189 HCl C25H23ClN6 1062368-62-0 Details
BML-275 C24H25N5O 866405-64-3 Details
6-Bromo-2-methylpyridine-3-carboxaldehyde C7H6BrNO 926293-55-2 Details
Dorsomorphin 2HCl (BML-275 2HCl) C24H27Cl2N5O 1219168-18-9 Details
5-CHLORO-2-(CHLOROMETHYL)PYRIDINE C6H5Cl2N 10177-24-9 Details
CNX-774 C26H22FN7O3 1202759-32-7 Details
6-bromo-4-chlorothieno[3,2-d]pyrimidine C6H2BrClN2S 225385-03-5 Details
LDN-193189 C25H22N6 1062368-24-4 Details
LDC1267 C30H26F2N4O5 1361030-48-9 Details
MK-2206 2HCl C25H22ClN5O 1032350-13-2 Details
PLERIXAFOR C28H54N8 110078-46-1 Details
Refametinib C19H20F3IN2O5S 923032-37-5 Details
Hexanoic acid,3-(aminomethyl)-5-methyl-, (3R)- C8H17NO2 148553-51-9 Details
hispidin C13H10O5 555-55-5 Details
UNC0379 C23H35N5O2 1620401-82-2 Details
UNC3866 C43H66N6O8 1872382-47-2 Details
VX-745 C19H9Cl2F2N3OS 209410-46-8 Details
VRT752271 C21H22Cl2N4O2 869886-67-9 Details
XY1 C17H19N3O2 1624117-53-8 Details
FIIN-3 C34H36Cl2N8O4 1637735-84-2 Details
YC-1 C19H16N2O2 170632-47-0 Details
EPI-001 C21H27ClO5 227947-06-0 Details
YO-01027 (Dibenzazepine) C26H23F2N3O3 209984-56-5 Details
SCH772984 C33H33N9O2 942183-80-4 Details
BAY85-3934 C13H14N8O2 1154028-82-6 Details
Emd1214063 C29H28N6O2 1100598-32-0 Details
BAW2881 C22H15F3N4O2 861875-60-7 Details
R1487 C19H19ClF2N4O3 449808-64-4 Details
APY29 C17H16N8 1216665-49-4 Details
AMG-47a C29H28F3N5O2 882663-88-9 Details
FH535 C13H10Cl2N2O4S 108409-83-2 Details
Mc-Val-Cit-PAB-PNP C35H43N7O11 159857-81-5 Details
(2,5-dimethylthiophen-3-yl)boronic acid C6H9BO2S 162607-23-0 Details
(R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide C20H21F3N2O2 953778-63-7 Details
(+)-MK 801 hydrogen maleate C20H19NO4 77086-22-7 Details
(1R)-1-[5-(2,2,2-trifluoroethoxy)-2-pyridyl]ethanamine C9H11F3N2O 953780-33-1 Details
(-)-MK 801 hydrogen maleate C20H19NO4 121917-57-5 Details
5-(2-amino-4-oxo-3-(2-(trifluoromethyl)phenyl)-3,4-dihydroquinazolin-6-yl)-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide C27H18F5N5O4S 1384097-27-1 Details
9a-(4-chlorobenzyl)-7-hydroxy-4-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1,2,9,9a-tetrahydro-3H-fluoren-3-one C33H34ClNO3 851107-28-3 Details
4-cyclopropylphenylacetic acid C11H12O2 40641-90-5 Details
2-(3,6-diacetyloxy-2,7-dichloro-9H-xanthen-9-yl)benzoic acid C24H16Cl2O7 4091-99-0 Details
Bz-Arg-Et C15H22N4O3 971-21-1 Details
MG-132 C26H41N3O5 133407-82-6 Details
BAY 80-6946 C23H28N8O4 1032568-63-0 Details
DOTA-PSMA(inhibitor) Details
DOTA-Tyr3-Octreotide C65H92N14O18S2 204318-14-9 Details
DOTA-HYNIC-PSMA(inhibitor) Details
HYNIC-Tyr3-Octreotide Details
HYNIC-PSMA(inhibitor) Details
Val-Cit-PAB-MMAE C58H94N10O12 644981-35-1 Details
Boc-Dap-NE C23H36N2O5 160800-65-7 Details
Mc-Val-Cit-PAB C28H40N6O7 159857-80-4 Details
Monomethylauristatin E C39H67N5O7 474645-27-7 Details
FMoc-Val-Cit-PAB-MMAE C73H104N10O14 1350456-56-2 Details
Fmoc-3vvd-OH C36H51N3O7 863971-44-2 Details
Val-Cit-PAB C18H29N5O4 159857-79-1 Details
Mc-Val-Cit-PAB-MMAE C68H105N11O15 646502-53-6 Details
Mc-MMAE C49H78N6O10 863971-24-8 Details
Fmoc-Val-Cit-PAB C33H39N5O6 159858-22-7 Details
MMAF C39H65N5O8 745017-94-1 Details
Fmoc-Val-Cit-PAB-PNP C40H42N6O10 863971-53-3 Details
Dolastatin 10 C42H68N6O6S 110417-88-4 Details
NSC-144303 C19H14N2O7S 108477-18-5 Details
SGI-7079 C26H26FN7 1239875-86-5 Details
Akti-1/2 C34H29N7O 612847-09-3 Details
VR23 C19H16ClN5O6S 1624602-30-7 Details
NSC348884 C38H40N10 81624-55-7 Details
Rhodamine 123 C21H17ClN2O3 62669-70-9 Details
(E)-3-[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyano-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]prop-2-enamide C23H13F9N4O3S 725247-18-7 Details
3,5-diamino-N-(N'-benzylcarbamimidoyl)-6-chloropyrazine-2-carboxamide,hydrochloride C13H15Cl2N7O 161804-20-2 Details
LY 294002 C19H18ClNO3 934389-88-5 Details
(5Z)-5-[(2,5-dimethyl-1-pyridin-3-ylpyrrol-3-yl)methylidene]-3-phenyl-1,3-thiazolidine-2,4-dione C21H17N3O2S 677331-12-3 Details
K-Ras(G12C) inhibitor C15H17ClIN3O3 1469337-95-8 Details
Voxtalisib C13H14N6O 934493-76-2 Details
EAI045 C19H14FN3O3S 1942114-09-1 Details
RK-33 C23H20N6O3 1070773-09-9 Details
AZ6102 C25H28N6O 1645286-75-4 Details
Product Total: Product Page:
1 2 3 4 5 6 7 8 9